MED

Medifast, Inc. (NASDAQ:MED) is a weight management and nutritional products company founded in 1980 and headquartered in Baltimore, Maryland. The company went public in 1993 and has evolved from a traditional diet company into a coach-supported weight loss platform. Medifast primarily operates through its OPTAVIA brand, which uses a network of independent health coaches to distribute meal replacement products and provide personalized weight management support. The company has faced significant challenges in recent years due to the emergence of GLP-1 weight loss medications like Ozempic and Wegovy, forcing a strategic pivot to adapt to the changing weight loss landscape.